Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 10/20 | 0.84 |
| ▸ | NR3C1 | P04150 | 8/20 | 0.84 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.84 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.84 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.84 |
| ▸ | PGR | P06401 | 2/20 | 0.84 |
| ▸ | SERPINA6 | P08185 | 2/20 | 0.84 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.84 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.84 |
| ▸ | MAPT | P10636 | 2/20 | 0.84 |
| ▸ | SHBG | P04278 | 1/20 | 0.84 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.84 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.84 |
| ▸ | LMNA | P02545 | 2/20 | 0.78 |
| ▸ | AR | P10275 | 1/20 | 0.77 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.77 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.69 |
| ▸ | TSHR | P16473 | 1/20 | 0.69 |
| ▸ | POLB | P06746 | 1/20 | 0.68 |
| ▸ | GAA | P10253 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19327149 | 1.00 | HIF1A (0.84) | HIF1ANR3C1SMN1; SMN2CYP2C19HSD17B10 | |
| SCHEMBL5488066 | 1.00 | HIF1A (0.84) | HIF1ANR3C1SMN1; SMN2CYP2C19HSD17B10 | |
| Hydrocortisone SCHEMBL19465688 | 0.91 | HIF1A (1.00) | HIF1ANR3C1SMN1; SMN2CYP2C19HSD17B10 | |
| SCHEMBL22476662 | 0.91 | HIF1A (0.85) | HIF1ANR3C1SMN1; SMN2CYP2C19HSD17B10 | |
| Hydrocortisone SCHEMBL1560948 | 0.91 | HIF1A (1.00) | HIF1ANR3C1SMN1; SMN2CYP2C19HSD17B10 | |
| Hydrocortisone SCHEMBL24900238 | 0.91 | HIF1A (1.00) | HIF1ANR3C1SMN1; SMN2CYP2C19HSD17B10 | |
| Hydrocortisone SCHEMBL6932400 | 0.91 | HIF1A (1.00) | HIF1ANR3C1SMN1; SMN2CYP2C19HSD17B10 | |
| SCHEMBL14513165 | 0.91 | HIF1A (0.85) | HIF1ANR3C1SMN1; SMN2CYP2C19HSD17B10 | |
| Hydrocortisone SCHEMBL143923 | 0.91 | HIF1A (1.00) | HIF1ANR3C1SMN1; SMN2CYP2C19HSD17B10 | |
| Hydrocortisone SCHEMBL1688689 | 0.91 | HIF1A (1.00) | HIF1ANR3C1SMN1; SMN2CYP2C19HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 7364 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4739293-A2 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF AUTOIMMUNE DISORDERS | AZURA OPHTHALMICS LTD (IL) | 2026-05-13 | — | — | EP | claimed |
| EP-4739291-A2 | ADMINISTRATION OF KERATOLYTICS TO OCULAR AND PERIOCULAR SURFACES | AZURA OPHTHALMICS LTD (IL) | 2026-05-13 | — | — | EP | claimed |
| EP-4255391-B1 | LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION | METRIOPHARM AG (CH) | 2026-05-06 | — | — | EP | claimed |
| WO-2026041906-A1 | SEMI-SOLID PHARMACEUTICAL COMPOSITION MICRO-DISPENSER | Azura Ophthalmics Ltd. (IL) | 2026-02-26 | — | — | WO | claimed |
| EP-4301343-B1 | PHARMACEUTICAL COMPOSITIONS WITH REDUCED SIDE EFFECT AND METHODS OF USING THE SAME | TLC BIOPHARMACEUTICALS INC (US) | 2025-11-19 | — | — | EP | claimed |
| US-20250322925-A1 | METHODS OF MANAGING EOSINOPHILIC ESOPHAGITIS | ELLODI PHARMACEUTICALS L P (US) | 2025-10-16 | — | — | US | claimed |
| EP-4616867-A1 | COMBINATION OF ENDOTHELIN RECEPTOR ANTAGONIST AND GLUCOCORTICOID FOR TREATING IGA NEPHROPATHY | Sanreno Therapeutics (Shanghai) Limited (CN) | 2025-09-17 | — | — | EP | claimed |
| US-20250255781-A1 | PROCESSES FOR PREPARATION OF 3-D PRINTED PHARMACEUTICAL PRODUCTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-08-14 | — | — | US | claimed |
| US-12377144-B2 | Methods of treating cancer using multi-specific binding proteins that bind NKG2D, CD16 and a tumor-associated antigen | DRAGONFLY THERAPEUTICS, INC. (US) | 2025-08-05 | — | — | US | claimed |
| EP-4590313-A1 | COMBINATION THERAPIES WITH ONCOLYTIC ADENOVIRUS AND TOPOISOMERASE I INHIBITORS OR PRODRUGS THEREOF | Theriva Biologics, S.L. (ES) | 2025-07-30 | — | — | EP | claimed |
| EP-0913154-A1 | Antipsoriatic nail lacquer | Hoechst Marion Roussel Deutschland GmbH (DE) | 1999-05-06 | — | — | EP | claimed |
| EP-0904266-A1 | NITROSATED AND NITROSYLATED COMPOUNDS AND COMPOSITIONS AND THEIR USE FOR TREATING RESPIRATORY DISORDERS | Nitromed, Inc. (US) | 1999-03-31 | — | — | EP | claimed |
| EP-0900233-A1 | NOVEL STEROID NITRITE AND NITRATE ESTER DERIVATIVES USEFUL AS ANTI-INFLAMMATORY DRUGS | G.D. SEARLE & CO. (US) | 1999-03-10 | — | — | EP | claimed |
| CN-1198676-A | Glucocorticold ehancement of gene expression | RES DEV FOUDATION (US) | 1998-11-11 | — | — | CN | claimed |
| WO-1998034595-A1 | MEDICAL AEROSOL FORMULATIONS | JAGO RESEARCH AG (CH) | 1998-08-13 | — | — | WO | claimed |
| WO-1997041144-A1 | NOVEL STEROID NITRITE AND NITRATE ESTER DERIVATIVES USEFUL AS ANTI-INFLAMMATORY DRUGS | G.D. SEARLE & CO. (US) | 1997-11-06 | — | — | WO | claimed |
| WO-1997034871-A1 | NITROSATED AND NITROSYLATED COMPOUNDS AND COMPOSITIONS AND THEIR USE FOR TREATING RESPIRATORY DISORDERS | NITROMED, INC. (US) | 1997-09-25 | — | — | WO | claimed |
| WO-1997020578-A1 | NON-PRESERVED TOPICAL CORTICOSTEROID FOR TREATMENT OF DRY EYE, FILAMENTARY KERATITIS, AND DELAYED TEAR CLEARANCE | UNIVERSITY OF MIAMI (US) | 1997-06-12 | — | — | WO | claimed |
| EP-0496520-A1 | Novel bone acting agents | MERCK & CO. INC. (US) | 1992-07-29 | — | — | EP | claimed |
| US-4877781-A | TIXOCORTOL PIVALATE, EPHEDRINE SULFATE, PRAMOXINE HYDROCHLORIDE; ANTIINFLAMMATORY AGENTS FOR HEMORRHOIDS | LaHaye, Peter G. (US) | 1989-10-31 | — | — | US | claimed |